ICH Q3E Guideline: Extractables & Leachables
The draft ICH Q3E Guideline establishes a harmonized, risk-based framework for managing extractables and leachables (E&L) throughout the lifecycle of drug products. Covering study design, toxicological qualification, acceptable exposure limits, and lifecycle monitoring, Q3E provides manufacturers with a consistent approach to assessing E&L risks while supporting patient safety and regulatory compliance.
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 10
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 10 Questions? Want to know more about our services? Call, mail, or send us a message. +32 493 10 65 08 info@agirad.com Contact us Other news News overview Update of Appendix 1 of the nitrosamine impurities guidance The nitrosamine Q&A document “Questions and answers for […]
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 9
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 9 Questions? Want to know more about our services? Call, mail, or send us a message. +32 493 10 65 08 info@agirad.com Contact us Other news News overview Update of Appendix 1 of the nitrosamine impurities guidance The nitrosamine Q&A document “Questions and answers for […]
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 8
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 8 Questions? Want to know more about our services? Call, mail, or send us a message. +32 493 10 65 08 info@agirad.com Contact us Other news News overview Update of Appendix 1 of the nitrosamine impurities guidance The nitrosamine Q&A document “Questions and answers for […]
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 7
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 7 Questions? Want to know more about our services? Call, mail, or send us a message. +32 493 10 65 08 info@agirad.com Contact us Other news News overview Update of Appendix 1 of the nitrosamine impurities guidance The nitrosamine Q&A document “Questions and answers for […]
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 6
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 6 Questions? Want to know more about our services? Call, mail, or send us a message. +32 493 10 65 08 info@agirad.com Contact us Other news News overview Update of Appendix 1 of the nitrosamine impurities guidance The nitrosamine Q&A document “Questions and answers for […]
Update of Appendix 1 of the nitrosamine impurities guidance Rev. 5
Update of Appendix 1 of the nitrosamine impurities guidance Questions? Want to know more about our services? Call, mail, or send us a message. +32 493 10 65 08 info@agirad.com Contact us Other news News overview Update of Appendix 1 of the nitrosamine impurities guidance The nitrosamine Q&A document “Questions and answers for marketing authorization […]